Trial Profile
A Randomised Placebo-controlled Trial of Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2022
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary) ; Misoprostol; Misoprostol; Misoprostol
- Indications Missed abortion
- Focus Therapeutic Use
- Acronyms MifeMiso
- 26 Aug 2020 Primary endpoint (Failure to spontaneously pass the gestational sac within 7 days after randomisation) has been met according to the results published in the Lancet
- 26 Aug 2020 Results published in the Lancet
- 08 Apr 2020 Status changed from active, no longer recruiting to completed.